2 researched Komodo Health entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer Precision Medicine Group is stuck in a commodity CRO trap—competing on price against IQVIA, ICON, and Parexel while watching oncology budgets tighten post-Blackstone/H&F ownership. The 2026 fix: anchor revenue to real-world-ev…
Read full answer ↗Direct Answer M Booth Health's revenue collapse = 3-year client stack concentration (pharma retainers) + zero bottom-funnel motion + ops debt = 40-50% margin compression. Fix: Shift from retainer defense → tiered outcome-linked pricing + CR…
Read full answer ↗